Document is current
Any future updates will be listed below
-
Authors
Tanaka, Atsushi
Ogawa, Makiko
Zhou, Yihua
Hendrickson, Ronald C.
Miele, Matthew M. https://orcid.org/0000-0001-7495-2133
Li, Zhuoning
Klimstra, David S.
Wang, Julia Y. https://orcid.org/0000-0002-9458-5825
Roehrl, Michael H. A. https://orcid.org/0000-0003-4892-1098
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R21 CA263262, U01 CA263986)
U.S. Department of Health & Human Services | National Institutes of Health
Neuroendocrine Tumor Research Foundation (N/A)
- License Information
-
More Information
Article History
Received: 3 May 2024
Accepted: 12 September 2024
First Online: 3 October 2024
Competing interests
: A.T., J.Y.W., Y.Z., M.O., and R.C.H. declare no conflicts of interest related to this study. D.S.K. is a consultant for and equity holder in Paige.AI and a consultant for Merck. M.H.R. is a member of the Scientific Advisory Board of Universal Diagnostics (UDX). None of these companies had any role in the support, design, execution, data analysis, or any other aspect of this study.
